{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:55:46Z","timestamp":1770540946221,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.humpath.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T21:03:21Z","timestamp":1649711001000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Aberrant expression of lymphoid enhancer\u2013binding factor 1 in Hodgkin lymphoma"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4503-440X","authenticated-orcid":false,"given":"Aishwarya","family":"Ravindran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Kurtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Rech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen D.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-4293","authenticated-orcid":false,"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.04.004_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1529","article-title":"WNT signalling and haematopoiesis: a WNT-WNT situation","volume":"5","author":"Staal","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2022.04.004_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0955-0674(99)80031-3","article-title":"Regulation of LEF-1\/TCF transcription factors by Wnt and other signals","volume":"11","author":"Eastman","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.humpath.2022.04.004_bib3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9440(10)64287-3","article-title":"Loss of expression of the WNT\/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas","volume":"162","author":"Dorfman","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12026-014-8545-9","article-title":"From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells","volume":"59","author":"Steinke","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.humpath.2022.04.004_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2022.01.001","article-title":"Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas","volume":"121","author":"Rangan","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma","volume":"182","author":"Walther","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2011.08907.x","article-title":"Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature","volume":"156","author":"Bockorny","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2022.04.004_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.23939","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma","volume":"90","author":"Parikh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2022.04.004_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41408-022-00616-6","article-title":"Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?","volume":"12","author":"King","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2022.04.004_bib13","series-title":"WHO classification of Tumours of haematopoietic and lymphoid tissues","year":"2017"},{"key":"10.1016\/j.humpath.2022.04.004_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.04.004_bib15","doi-asserted-by":"crossref","first-page":"33398","DOI":"10.1074\/jbc.M107977200","article-title":"Wnt-3A\/beta-catenin signaling induces transcription from the LEF-1 promoter","volume":"277","author":"Filali","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2022.04.004_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0501-53","article-title":"Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer","volume":"28","author":"Hovanes","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2022.04.004_bib17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.280.5367.1274","article-title":"Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud","volume":"280","author":"Kengaku","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.humpath.2022.04.004_bib18","doi-asserted-by":"crossref","first-page":"151636","DOI":"10.1016\/j.anndiagpath.2020.151636","article-title":"Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma","volume":"49","author":"Lyapichev","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2016.232","article-title":"Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma","volume":"31","author":"Linke","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.04.004_bib20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V95.3.1023.003k07_1023_1031","article-title":"Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease","volume":"95","author":"Kanzler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.04.004_bib21","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/annonc\/9.suppl_5.S17","article-title":"Clonality and germinal centre B-cell derivation of Hodgkin\/Reed-Sternberg cells in Hodgkin's disease","volume":"9","author":"Kuppers","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.04.004_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.04.004_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.2005.05426.x","article-title":"Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine","volume":"129","author":"Fong","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2022.04.004_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF03402211","article-title":"Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL","volume":"7","author":"Kuppers","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.humpath.2022.04.004_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s004280000214","article-title":"Hodgkin\/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background","volume":"437","author":"Pescarmona","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.04.004_bib26","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/jcb.24803","article-title":"Factors affecting the nuclear localization of beta-catenin in normal and malignant tissue","volume":"115","author":"Morgan","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.humpath.2022.04.004_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1066896913513833","article-title":"Utility of LRF\/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma","volume":"22","author":"Bohn","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.04.004_bib28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/leu.2008.101","article-title":"Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma","volume":"22","author":"Jundt","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.04.004_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067306","article-title":"Gauging NOTCH1 activation in cancer using immunohistochemistry","volume":"8","author":"Kluk","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.04.004_bib30","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.04.004_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/leu.2011.265","article-title":"Notch is an essential upstream regulator of NF-kappaB and is relevant for survival of Hodgkin and Reed-Sternberg cells","volume":"26","author":"Schwarzer","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.04.004_bib32","article-title":"Characterization of LEF1 high expression and novel mutations in adult acute lymphoblastic leukemia","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.04.004_bib33","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1182\/blood-2007-04-084202","article-title":"Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas","volume":"110","author":"Spaulding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.04.004_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fonc.2018.00229","article-title":"NOTCH1 aberrations in chronic lymphocytic leukemia","volume":"8","author":"Rosati","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2022.04.004_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000001614","article-title":"Striking association of lymphoid enhancing factor (LEF1) overexpression and DUSP22 rearrangements in anaplastic large cell lymphoma","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:40Z","timestamp":1758645580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772200082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":35,"alternative-id":["S004681772200082X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.04.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant expression of lymphoid enhancer\u2013binding factor 1 in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}